Vishal Retail......Issue Price Arnd 250....shld list arnd 400-425...one can book profit arnd those levels
Indian Overses Bank....one can buy this with a stoploss of 110 and a target of 130...pure technical call
Era Construction...buy with a stoploss of 340 n target of 405
Technically Litaka pharma is looking strong...accumulation seems to be taking place in it....target being heard of is arnd 150 in 6 months....though news is unconfirmed.
SOME UPDATES:
1. TORRENT PHARMA LIKELY TO OUTSOURCE 5 CR TABLETS PER MONTH FROM TLPL. 2. PROMOTERS EQUITY UNDER LOCK-IN UPTO OCT 09
3. CONFIDENT OF 30% GROWTH IN TURNOVER AND 50% GROWTH IN PBT EACH YEAR FOR NEXT 3 YEARS DUE TO MAJOR THRUST IN DOMEST MARKET OWN BRANDED SALES
SO FAR, SCRIP HAS GONE UP PURELY DUE TO RETAIL BUYING. NOW, SCRIP IS UNDER SCANNER OF HNI INVESTORS, BROKERS, FI AND FIIs. ONCE BUYING START FROM THIS SEGMENT , SHARE PRICE CAN ZOOM TO RS 140/ IN 3-6 MONTHS DUE TO LIMITED FLOATING STOCK.
NavaBharat Ventures
Shift of business focus from ferro alloys towards power to yield rich dividends.
NB Ventures has realigned its business strategy towards the rapidly growing power sector. The company's power division contributed 95 per cent of EBIT in FY07, with an EBIT margin of 50 per cent. Power Capacity is being ramped up from 121 MW to 237 MW by FY09. Also, a 1050 MW Power Plant is to be set up by 2010-11 with Power Purchase Agreements secured for 75 per cent of power generated. The highly volatile ferro alloy business has been de-risked by power sales, since the company now has the flexibility to shut down its ferro alloy unit and sell power in case of fluctuating prices. Substantial value present in land holdings, comprising a 51 per cent stake in an upcoming 250 acre SEZ project and ownership of 68 acres in Secunderabad.
On the SOTP approach, NB Ventures seems a good buy with a target of Rs 268, a 64 per cent upside from current levels. The proposed 1050 MW Orissa Power Plant and value of land holdings has not been factored into the estimates.
4 comments:
Torrent Pharma is already trading around 250. What do you mean by "Stock will zoom to 140 levels"?
i was tlking abt litika pharma which will touch 150....torrent pharma is a client of LTPL....hope ur doubt is cleared
Is litika a better play than sanjivani (recoed by you earlier) in pharma sector? Rumors of interim dividend + v strong march results for sanjivani.
By the way, do you have a boarder id in moneycontrol?
Regards
yup litaka is a better player than sanjivani plus management is more reliable...sanjivani call was giving then n profitbooking was also suggested at higher levels....sanjivani management is not reliable so no investment call is advised on it...though one can buy arnd 27 for pure technical play n sell arnd 35....risky one though.....i dont hold any investment in the same....will pick litaka at declines..dont hold position as of now...ashu
Post a Comment